<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Immunol.</journal-id>
<journal-title>Frontiers in Immunology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Immunol.</abbrev-journal-title>
<issn pub-type="epub">1664-3224</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fimmu.2018.00207</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Immunology</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Elevated Systemic Levels of Eosinophil, Neutrophil, and Mast Cell Granular Proteins in <italic>Strongyloides Stercoralis</italic> Infection that Diminish following Treatment</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name><surname>Rajamanickam</surname> <given-names>Anuradha</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="corresp" rid="cor1">&#x0002A;</xref>
<uri xlink:href="http://frontiersin.org/people/u/417188"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Munisankar</surname> <given-names>Saravanan</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Bhootra</surname> <given-names>Yukthi</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Dolla</surname> <given-names>Chandra Kumar</given-names></name>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Nutman</surname> <given-names>Thomas B.</given-names></name>
<xref ref-type="aff" rid="aff3"><sup>3</sup></xref>
<uri xlink:href="http://frontiersin.org/people/u/76862"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Babu</surname> <given-names>Subash</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff3"><sup>3</sup></xref>
</contrib>
</contrib-group>
<aff id="aff1"><sup>1</sup><institution>National Institutes of Health &#x02013; National Institute of Research in Tuberculosis (ICMR) &#x02013; International Center for Excellence in Research</institution>, <addr-line>Chennai</addr-line>, <country>India</country></aff>
<aff id="aff2"><sup>2</sup><institution>National Institute of Research in Tuberculosis (ICMR)</institution>, <addr-line>Chennai</addr-line>, <country>India</country></aff>
<aff id="aff3"><sup>3</sup><institution>Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health</institution>, <addr-line>Bethesda, MD</addr-line>, <country>United States</country></aff>
<author-notes>
<fn fn-type="edited-by"><p>Edited by: Hyun Soon Lillehoj, Beltsville Agricultural Research Center (USDA-ARS), United States</p></fn>
<fn fn-type="edited-by"><p>Reviewed by: William Horsnell, University of Cape Town, South Africa; Woo Hyun Kim, Beltsville Agricultural Research Center (USDA-ARS), United States; Atul Chaudhari, Alabama State University, United States</p></fn>
<corresp content-type="corresp" id="cor1">&#x0002A;Correspondence: Anuradha Rajamanickam, <email>anuradha&#x00040;nirt.res.in</email></corresp>
<fn fn-type="other" id="fn001"><p>Specialty section: This article was submitted to Microbial Immunology, a section of the journal Frontiers in Immunology</p></fn>
</author-notes>
<pub-date pub-type="epub">
<day>09</day>
<month>02</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="collection">
<year>2018</year>
</pub-date>
<volume>9</volume>
<elocation-id>207</elocation-id>
<history>
<date date-type="received">
<day>13</day>
<month>10</month>
<year>2017</year>
</date>
<date date-type="accepted">
<day>24</day>
<month>01</month>
<year>2018</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#x000A9; 2018 Rajamanickam, Munisankar, Bhootra, Dolla, Nutman and Babu.</copyright-statement>
<copyright-year>2018</copyright-year>
<copyright-holder>Rajamanickam, Munisankar, Bhootra, Dolla, Nutman and Babu</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/"><p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p></license>
</permissions>
<abstract>
<p>Infection with the helminth parasite <italic>Strongyloides stercoralis</italic> (<italic>Ss</italic>) is commonly clinically asymptomatic that is often accompanied by peripheral eosinophilia. Granulocytes are activated during helminth infection and can act as immune effector cells. Plasma levels of eosinophil and neutrophil granular proteins convey an indirect measure of granulocyte degranulation and are prominently augmented in numerous helminth-infected patients. In this study, we sought to examine the levels of eosinophil, neutrophil, and mast cell activation-associated granule proteins in asymptomatic <italic>Ss</italic> infection and to understand their kinetics following anthelmintic therapy. To this end, we measured the plasma levels of eosinophil cationic protein, eosinophil-derived neurotoxin, eosinophil peroxidase, eosinophil major basic protein, neutrophil elastase, myeloperoxidase, neutrophil proteinase-3, mast cell tryptase, leukotriene C4, and mast cell carboxypeptidase-A3 in individuals with asymptomatic <italic>Ss</italic> infection or without <italic>Ss</italic> infection [uninfected (UN)]. We also estimated the levels of all of these analytes in infected individuals following definitive treatment of <italic>Ss</italic> infection. We demonstrated that those infected individuals have significantly enhanced plasma levels of eosinophil cationic protein, eosinophil-derived neurotoxin, eosinophil peroxidase, eosinophil major basic protein, elastase, myeloperoxidase, mast cell tryptase, leukotriene C4, and carboxypeptidase-A3 compared to UN individuals. Following the treatment of <italic>Ss</italic> infection, each of these granulocyte-associated proteins drops significantly. Our data suggest that eosinophil, neutrophil, and mast cell activation may play a role in the response to <italic>Ss</italic> infection.</p>
</abstract>
<kwd-group>
<kwd>eosinophils</kwd>
<kwd>neutrophils</kwd>
<kwd>mast cells</kwd>
<kwd>granular proteins</kwd>
<kwd>helminths</kwd>
<kwd><italic>Strongyloides stercoralis</italic></kwd>
</kwd-group>
<counts>
<fig-count count="4"/>
<table-count count="1"/>
<equation-count count="0"/>
<ref-count count="51"/>
<page-count count="9"/>
<word-count count="5392"/>
</counts>
</article-meta>
</front>
<body>
<sec id="S1" sec-type="introduction">
<title>Introduction</title>
<p><italic>Strongyloides stercoralis (Ss)</italic>, an intestinal parasitic nematode, infects 30&#x02013;100 million people worldwide (<xref ref-type="bibr" rid="B1">1</xref>). The clinical manifestation of <italic>Ss</italic> can range from clinically asymptomatic to, at its most severe, a potentially fatal disseminated infection. Granulocytes are activated during helminth infection and act as immune effector cells. <italic>In vitro</italic> granulocyte mediated immunity against helminths can be attained through antibody-dependent cell-mediated cytotoxicity, and antibody attaches to the parasite&#x02019;s cell surface and triggers degranulation and extrusion of toxic granule contents against the parasite (<xref ref-type="bibr" rid="B2">2</xref>).</p>
<p>In healthy people, eosinophils normally constitute only 2&#x02013;5% of peripheral leukocytes. However, during active helminth infection, the eosinophils fraction in the blood can increase to more than 40% (<xref ref-type="bibr" rid="B3">3</xref>). Eosinophils have eosinophil-specific toxic proteins stored in their secondary granules. These include eosinophil cationic protein (ECP), eosinophil peroxidase (EPX), eosinophil-derived neurotoxin (EDN), and eosinophil major basic protein (MBP). ECP, EPX, and MBP are potent helminth toxins (<xref ref-type="bibr" rid="B4">4</xref>). MBP can provoke histamine release from mast cells; however, EDN and ECP can act as ribonucleases (<xref ref-type="bibr" rid="B4">4</xref>, <xref ref-type="bibr" rid="B5">5</xref>). Experimental helminth infection studies revealed that eosinophils accumulate in the gastrointestinal tract, where it is believed that they assist to eliminate parasites (<xref ref-type="bibr" rid="B6">6</xref>). Interestingly, evidence suggests that there could be dissimilarities in the mechanisms of eosinophil-mediated killing among different life cycle stages of the same parasite (<xref ref-type="bibr" rid="B7">7</xref>).</p>
<p>Among granulocytes, neutrophils are effective at phagocytosis, and they can engulf and execute microorganisms by producing reactive oxygen intermediates in phagolysosomes. Conversely, helminths are very large to be phagocytosed, and as a outcome, the function of neutrophils in helminth-driven effector responses has been ignored till now (<xref ref-type="bibr" rid="B2">2</xref>). Neutrophils can be defensive against nematode parasites, and this has been exhibited conclusively in the <italic>Strongyloides sp</italic>. model (<xref ref-type="bibr" rid="B8">8</xref>). Like neutrophils, granulocytes are also critical in controlling <italic>Streptococcus ratti</italic> in mice (<xref ref-type="bibr" rid="B9">9</xref>). Myeloperoxidase (MPO) purified from human neutrophils is toxic to <italic>Trichinella spiralis</italic> and <italic>Schistosoma mansoni</italic> (<xref ref-type="bibr" rid="B10">10</xref>, <xref ref-type="bibr" rid="B11">11</xref>) and functions in killing <italic>S. stercoralis</italic> larvae (<xref ref-type="bibr" rid="B12">12</xref>). Neutrophil elastase (NE) secreted following contact with <italic>S. mansoni</italic> is potentially toxic to a number of stages of this parasite (<xref ref-type="bibr" rid="B13">13</xref>).</p>
<p>Mast cells also play an important role in parasitic infections and have been implicated in the regulation of innate and adaptive immune responses following infection (<xref ref-type="bibr" rid="B14">14</xref>). Helminth infections are associated with elevations in tissue mast cell numbers (<xref ref-type="bibr" rid="B15">15</xref>). In the presence of helminth antigens, Fc&#x003B5;RI receptor provokes mast cell degranulation, which results in the release of mast cell tryptase (MCT), carboxypeptidase-A3 (CPA-3), and leukotriene C4 (LTC4), which has direct cytotoxic effect on helminths (<xref ref-type="bibr" rid="B15">15</xref>, <xref ref-type="bibr" rid="B16">16</xref>). During helminth infection, studies have revealed that mast cells are crucial in the expulsion of several helminth species from the gastrointestinal tract (<xref ref-type="bibr" rid="B17">17</xref>) including <italic>T. spiralis, Nippostrongylus brasiliensis</italic>, and <italic>S. ratti</italic> in rodent models (<xref ref-type="bibr" rid="B18">18</xref>, <xref ref-type="bibr" rid="B19">19</xref>).</p>
<p>In this study, we wanted to characterize the presence and persistence of eosinophil, neutrophil, and mast cell degranulation proteins in <italic>Ss</italic> infection before and after treatment. We hypothesized that the plasma levels of granular proteins would reflect the activation profile of these important granulocyte subsets and its association to <italic>Ss</italic> infection. To this end, we measured the plasma levels of eosinophil granular proteins (ECP, EDN, EPX, and MBP), neutrophil granular proteins [NE, MPO, and proteinase-3 (PTN-3)], and mast cell granular proteins and mediators (MCT, LTC4, and CPA-3) in <italic>Ss</italic>-infected (INF) and <italic>Ss</italic>-uninfected (UN) individuals. Plasma levels of ECP, EPX, EDN, MBP, NE, MPO, MCT, LTC4, and CPA-3 levels were all significantly increased in <italic>Ss</italic> infection compared to those without <italic>Ss</italic> infection. These levels decreased significantly after anthelmintic treatment.</p>
</sec>
<sec id="S2" sec-type="materials|methods">
<title>Materials and Methods</title>
<sec id="S2-1">
<title>Ethics Statement</title>
<p>All participants were examined as a part of a natural history study protocol (12-I-073) approved by Institutional Review Boards of the National Institute of Allergy and Infectious Diseases (USA) and the National Institute for Research in Tuberculosis (India), and informed written consent was obtained from all participants.</p>
</sec>
<sec id="S2-2">
<title>Study Population</title>
<p>We studied a total of 118 individuals including of 60 clinically asymptomatic, INF individuals and 58 UNF, endemic healthy individuals in Tamil Nadu, South India (Table <xref ref-type="table" rid="T1">1</xref>). These individuals were all enrolled from a rural population. None had previous anthelmintic treatment, a history of helminth infections, or HIV. The INF individuals were followed up after 6&#x02009;months of anthelmintic treatment.</p>
<table-wrap position="float" id="T1">
<label>Table 1</label>
<caption><p>Baseline demographics of the study population.</p></caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th valign="top" align="left">Study demographics</th>
<th valign="top" align="left">Ss infected (INF)</th>
<th valign="top" align="left">Ss uninfected (UN)</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" valign="top">Number</td>
<td align="left" valign="top">60</td>
<td align="left" valign="top">58</td>
</tr>
<tr>
<td align="left" valign="top">Gender (male/female)</td>
<td align="left" valign="top">33/27</td>
<td align="left" valign="top">35/23</td>
</tr>
<tr>
<td align="left" valign="top">Median age (range)</td>
<td align="left" valign="top">36 (20&#x02013;65)</td>
<td align="left" valign="top">39 (20&#x02013;60)</td>
</tr>
<tr>
<td align="left" valign="top">NIE ELISA</td>
<td align="left" valign="top">Positive</td>
<td align="left" valign="top">Negative</td>
</tr>
</tbody>
</table>
</table-wrap>
<p><italic>Strongyloides stercoralis</italic> infection was detected by measuring IgG antibodies to the recombinant NIE antigen, as explained elsewhere (<xref ref-type="bibr" rid="B20">20</xref>, <xref ref-type="bibr" rid="B21">21</xref>). Further confirmation was done using specialized stool examination with nutrient agar plate cultures (<xref ref-type="bibr" rid="B22">22</xref>). None of the study population had lymphatic filariasis (based on ELISA) or other intestinal helminths (based on the stool microscopy). All INF individuals were treated with single doses of ivermectin and albendazole, and follow-up blood draws were collected after 6&#x02009;months. Treated individuals were <italic>Ss</italic> infection negative by stool microscopy at 6&#x02009;months posttreatment (post-T). All UN individuals were negative for anti-<italic>Ss</italic>-NIE and for filarial and other intestinal helminths.</p>
</sec>
<sec id="S2-3">
<title>Measurement of Hematological Parameters</title>
<p>Hematological parameters were measured from fresh venous EDTA blood samples on all individuals using an ACT 5 Diff. hematology analyzer (Beckman Coulter, Brea, CA, USA).</p>
</sec>
<sec id="S2-4">
<title>Measurement of Eosinophils, Neutrophils, and Mast Cell Granular Proteins</title>
<p>Plasma levels of ECP, EDN, EPX, MBP (MyBiosource, Inc., San Diego, CA, USA), MPO, PTN-3 (R&#x00026;D Systems, Minneapolis, MN, USA), NE (Cell Sciences Hycult Biotech, Canton, MA, USA), MCT, LTC4, and CPA-3 were measured using the Mybiosource ELISA kits (MyBiosource, Inc., San Diego, CA, USA), followed the manufacturer&#x02019;s protocol. The detection limits were as follows: ECP, 1.56&#x02013;100&#x02009;ng/ml; EDN, 0.625&#x02013;40&#x02009;ng/ml; EPX, 78&#x02013;5,000&#x02009;pg/ml; MBP, 0.468&#x02013;30&#x02009;ng/ml; MPO, 62.50&#x02013;4,000&#x02009;pg/ml; PTN-3, 15.6&#x02013;1,000&#x02009;pg/ml; NE, 0.4&#x02013;25&#x02009;ng/ml; MCT, 3.12&#x02013;100&#x02009;ng/ml; LTC4, 78&#x02013;5,000&#x02009;pg/ml; and CPA-3, 0.78&#x02013;50&#x02009;ng/ml. We have assigned the lowest standard value to the samples that were below the threshold of detection.</p>
</sec>
<sec id="S2-5">
<title>Statistical Analysis</title>
<p>Data analyses were done using GraphPad PRISM 7 (GraphPad Software, Inc., San Diego, CA, USA). Central tendency was calculated using geometric mean (GM). Nonparametric Mann&#x02013;Whitney <italic>U</italic> test and Wilcoxon matched pair test were used to calculate the statistical significant difference. Multiple comparisons were corrected using the Holm&#x02019;s correction. JMP 13 (SAS) software was used to perform Spearman rank correlation matrix.</p>
</sec>
</sec>
<sec id="S3">
<title>Results</title>
<sec id="S3-1">
<title><italic>Ss</italic> Infection Is Associated with Elevated Absolute Neutrophil and Eosinophil Counts and Reversal following Treatment</title>
<p>As shown in Table <xref ref-type="table" rid="T1">1</xref>, there was no significant difference in age or gender between the two groups. We measured the hematological parameters in the two groups. As shown in Figure <xref ref-type="fig" rid="F1">1</xref>A, INF had significantly enhanced levels of neutrophils (GM of 6,566/&#x003BC;l in INF Vs GM of 4,848/&#x003BC;l in UN; <italic>p</italic>&#x02009;&#x0003D;&#x02009;0.0001) and eosinophils (GM of 550/&#x003BC;l in INF vs GM of 281/&#x003BC;l in UN; <italic>p</italic>&#x02009;&#x0003C;&#x02009;0.0001) in comparison with UN individuals. The other hematological parameters did not show any significant difference between the two groups. Upon anthelminthic treatment, the absolute numbers were significantly reversed. As shown in Figure <xref ref-type="fig" rid="F1">1</xref>B, absolute counts of neutrophils [GM of 6,566/&#x003BC;l in pretreatment (pre-T) vs GM of 6,000/&#x003BC;l in post-T; <italic>p</italic>&#x02009;&#x0003C;&#x02009;0.0001] and eosinophils (GM of 550/&#x003BC;l in pre-T Vs GM of 483/&#x003BC;l in post-T; <italic>p</italic>&#x02009;&#x0003C;&#x02009;0.0001) were significantly decreased. Other hematological parameters did not show any significant changes following treatment.</p>
<fig id="F1" position="float">
<label>Figure 1</label>
<caption><p><italic>Strongyloides stercoralis</italic> (<italic>Ss</italic>) infection is associated with elevated absolute neutrophil and eosinophil counts and reversal following treatment. <bold>(A)</bold> Absolute counts of hematological parameters from Ss-infected (INF; <italic>n</italic>&#x02009;&#x0003D;&#x02009;60) or uninfected (UN; <italic>n</italic>&#x02009;&#x0003D;&#x02009;58) individuals were measured. Data are shown as scatter plots with the bar representing the geometric mean. <italic>p</italic> Values were calculated using the Mann&#x02013;Whitney test with Holm&#x02019;s correction for multiple comparisons. <bold>(B)</bold> Absolute counts of hematological parameters from Ss-infected pretreatment (pre-T; <italic>n</italic>&#x02009;&#x0003D;&#x02009;60) and 6&#x02009;months after treatment posttreatment (post-T) individuals were measured. <italic>p</italic> Values were calculated using the Wilcoxon matched pair test with Holm&#x02019;s correction for multiple comparisons.</p></caption>
<graphic xlink:href="fimmu-09-00207-g001.tif"/>
</fig>
</sec>
<sec id="S3-2">
<title><italic>Ss</italic> Infection Is Associated with Elevated Levels of Eosinophils, Neutrophils, and Mast Cell Granular Proteins</title>
<p>To characterize the role of eosinophils, neutrophils, mast cell granular proteins, and lipid mediators in <italic>Ss</italic> infection, we measured the plasma levels of eosinophil granular proteins (ECP, EDN, EPX, and MBP), neutrophil granular proteins (NE, MPO, and PTN-3), mast cell granular proteins, and lipid mediator (MCT, LTC4, and CPA-3) in INF and UN individuals. As shown in Figure <xref ref-type="fig" rid="F2">2</xref>A, INF had significantly higher levels of ECP (GM of 71.18&#x02009;ng/ml in INF vs. 48.59&#x02009;ng/ml in UN; <italic>p</italic>&#x02009;&#x0003D;&#x02009;0.0007), EDN (GM of 1.811&#x02009;ng/ml in INF vs. 1.014&#x02009;ng/ml in UN; <italic>p</italic>&#x02009;&#x0003D;&#x02009;0.0072), EPX (GM of 1,1945&#x02009;ng/ml in INF vs. 7,407&#x02009;ng/ml in UN; <italic>p</italic>&#x02009;&#x0003D;&#x02009;0.0065), and MBP (GM of 288.4&#x02009;ng/ml in INF vs. 223.7&#x02009;ng/ml in UN; <italic>p</italic>&#x02009;&#x0003D;&#x02009;0.0464) in comparison to UN individuals. As shown in Figure <xref ref-type="fig" rid="F2">2</xref>B, INF had significantly enhanced levels of NE (GM of 8,456&#x02009;ng/ml in INF vs. 6,422&#x02009;ng/ml in UN; <italic>p</italic>&#x02009;&#x0003D;&#x02009;0.0363) and MPO (GM of 45.12&#x02009;pg/ml in INF vs. 37.26&#x02009;pg/ml in UN; <italic>p</italic>&#x02009;&#x0003D;&#x02009;0.0340) in comparison to UN individuals. As shown in Figure <xref ref-type="fig" rid="F2">2</xref>C, INF had significantly increased levels of MCT (GM of 8,456&#x02009;ng/ml in INF vs. 6,422&#x02009;ng/ml in UN; <italic>p</italic>&#x02009;&#x0003D;&#x02009;0.0363), LTC4 (GM of 45.12&#x02009;pg/ml in INF vs. 37.26&#x02009;pg/ml in UN; <italic>p</italic>&#x02009;&#x0003D;&#x02009;0.0340), and CPA-3 (GM of 45.12&#x02009;pg/ml in INF vs. 37.26&#x02009;pg/ml in UN; <italic>p</italic>&#x02009;&#x0003D;&#x02009;0.0340) in comparison to UN individuals.</p>
<fig id="F2" position="float">
<label>Figure 2</label>
<caption><p><italic>Strongyloides stercoralis</italic> (<italic>Ss</italic>) infection is associated with elevated levels of eosinophils, neutrophils, and mast cell granular proteins. <bold>(A)</bold> Plasma levels of eosinophil cationic protein (ECP), eosinophil-derived neurotoxin (EDN), eosinophil peroxidase (EPX), and major basic protein (MBP), from <italic>Ss</italic>-infected (INF; <italic>n</italic>&#x02009;&#x0003D;&#x02009;60) or <italic>Ss</italic>-uninfected (UN; <italic>n</italic>&#x02009;&#x0003D;&#x02009;58) individuals were measured by ELISA. Data are shown as scatter plots with the bar representing the geometric mean. <italic>p</italic> Values were calculated using the Mann&#x02013;Whitney test. <bold>(B)</bold> Plasma levels of plasma levels of neutrophil elastase (NE), myeloperoxidase (MPO), and proteinase-3 (PTN-3) from (INF; <italic>n</italic>&#x02009;&#x0003D;&#x02009;60) or (UN; <italic>n</italic>&#x02009;&#x0003D;&#x02009;58) individuals were measured by ELISA. Data are shown as scatter plots with the bar representing the geometric mean. <italic>p</italic> Values were calculated using the Mann&#x02013;Whitney test. <bold>(C)</bold> Plasma levels of plasma levels of mast cell tryptase (MCT), leukotriene C4 (LTC4), and carboxypeptidase A-3 (CPA-3) from INF (<italic>n</italic>&#x02009;&#x0003D;&#x02009;60) or UN (<italic>n</italic>&#x02009;&#x0003D;&#x02009;58) individuals were measured by ELISA. Data are shown as scatter plots with the bar representing the geometric mean. <italic>p</italic> Values were calculated using the Mann&#x02013;Whitney test with Holm&#x02019;s correction for multiple comparisons.</p></caption>
<graphic xlink:href="fimmu-09-00207-g002.tif"/>
</fig>
</sec>
<sec id="S3-3">
<title><italic>Ss</italic> Infection Is Associated with Decreased Levels of Eosinophils, Neutrophils, and Mast Cell Granular Proteins following Anthelminthic Treatment</title>
<p>To determine the outcome of treatment on the levels of these granulocyte-associated proteins in those with <italic>Ss</italic> infection, all INF individuals were treated, and the levels of eosinophil granular proteins (ECP, EDN, EPX, and MBP), neutrophil granular proteins (NE, MPO, and PTN-3), and mast cell products (MCT, LTC4, and CPA-3) were measured in INF individuals before and after anthelminthic treatment. As shown in Figure <xref ref-type="fig" rid="F3">3</xref>A, the systemic levels of ECP (GM of 71.18&#x02009;ng/ml in pre-T vs. 57.78&#x02009;ng/ml in post-T; <italic>p</italic>&#x02009;&#x0003D;&#x02009;0.0007), EDN (GM of 1.811&#x02009;ng/ml in pre-T vs. 1.365&#x02009;ng/ml in post-T; <italic>p</italic>&#x02009;&#x0003D;&#x02009;0.0006), EPX (GM of 1,1945&#x02009;ng/ml in pre-T vs. 1,1146&#x02009;ng/ml in post-T; <italic>p</italic>&#x02009;&#x0003D;&#x02009;0.0005), and MBP (GM of 288.4&#x02009;ng/ml in pre-T vs. 167&#x02009;ng/ml in post-T; <italic>p</italic>&#x02009;&#x0003D;&#x02009;0.0084) were significantly decreased in INF individuals following anthelmintic treatment. For the neutrophil-associated proteins, as shown in Figure <xref ref-type="fig" rid="F3">3</xref>B, the systemic levels of NE (GM of 8,456&#x02009;ng/ml in pre-T vs. 4,491&#x02009;ng/ml in post-T; <italic>p</italic>&#x02009;&#x0003D;&#x02009;0.0081) and MPO (GM of 45.12&#x02009;pg/ml in pre-T vs. 36.58&#x02009;pg/ml in post-T; <italic>p</italic>&#x02009;&#x0003D;&#x02009;0.0088) were significantly decreased in INF individuals following anthelmintic treatment. Furthermore, the systemic levels of MCT (GM of 8,456&#x02009;ng/ml in pre-T vs. 4,491&#x02009;ng/ml in post-T; <italic>p</italic>&#x02009;&#x0003D;&#x02009;0.0081), LTC4 (GM of 45.12&#x02009;pg/ml in pre-T vs. 36.58&#x02009;pg/ml in post-T; <italic>p</italic>&#x02009;&#x0003D;&#x02009;0.0088), and CPA-3 (GM of 45.12&#x02009;pg/ml in pre-T vs. 36.58&#x02009;pg/ml in post-T; <italic>p</italic>&#x02009;&#x0003D;&#x02009;0.0088) were also significantly diminished in INF individuals following anthelmintic treatment (Figure <xref ref-type="fig" rid="F3">3</xref>C).</p>
<fig id="F3" position="float">
<label>Figure 3</label>
<caption><p><italic>Strongyloides stercoralis</italic> (<italic>Ss</italic>) infection is associated with decreased levels of eosinophils, neutrophils, and mast cell granular proteins following anthelminthic treatment. <bold>(A)</bold> Plasma levels of eosinophil cationic protein (ECP), eosinophil-derived neurotoxin (EDN), eosinophil peroxidase (EPX), and major basic protein (MBP), from <italic>Ss</italic>-infected pre treatment (pre-T; <italic>n</italic>&#x02009;&#x0003D;&#x02009;60) and 6&#x02009;months following treatment from posttreatment (post-T) individuals were measured by ELISA. <italic>p</italic>&#x02009;Values were calculated using the Wilcoxon matched pair test. <bold>(B)</bold> Plasma levels of neutrophil elastase (NE), myeloperoxidase (MPO), and proteinase-3 (PTN-3) from <italic>Ss</italic> infected (pre-T; <italic>n</italic>&#x02009;&#x0003D;&#x02009;60) and 6&#x02009;months following treatment from post-T individuals were measured by ELISA. <italic>p</italic>&#x02009;Values were calculated using the Wilcoxon matched pair test. <bold>(C)</bold> Plasma levels of mast cell tryptase (MCT), leukotriene C4 (LTC4), and carboxypeptidase A3 (CPA-3) from <italic>Ss</italic>-infected (pre-T; <italic>n</italic>&#x02009;&#x0003D;&#x02009;60) and 6&#x02009;months following treatment from post-T individuals were measured by ELISA. <italic>p</italic>&#x02009;Values were calculated using the Wilcoxon matched pair test with Holm&#x02019;s correction for multiple comparisons.</p></caption>
<graphic xlink:href="fimmu-09-00207-g003.tif"/>
</fig>
</sec>
<sec id="S3-4">
<title>Relationship between Eosinophils, Neutrophils, and Mast Cell Granular Protein Levels and Absolute Numbers of Eosinophils, Neutrophils, and Basophils in INF Individuals</title>
<p>The relationships between the levels of eosinophils, neutrophils, and mast cell granular proteins and the absolute numbers of eosinophils, neutrophils, and basophils were next assessed (Figure <xref ref-type="fig" rid="F4">4</xref>A). There was a significant positive correlation between absolute eosinophil count (AEC) and the levels of ECP (<italic>r</italic>&#x02009;&#x0003D;&#x02009;0.2413; <italic>p</italic>&#x02009;&#x0003D;&#x02009;0.0085), EPX (<italic>r</italic>&#x02009;&#x0003D;&#x02009;0.2196; <italic>p</italic>&#x02009;&#x0003D;&#x02009;0.0169), and MBP (<italic>r</italic>&#x02009;&#x0003D;&#x02009;0.1918; <italic>p</italic>&#x02009;&#x0003D;&#x02009;0.0375). There was also a significant positive correlation between levels of NE (<italic>r</italic>&#x02009;&#x0003D;&#x02009;0.2637; <italic>p</italic>&#x02009;&#x0003D;&#x02009;0.0039) and MPO (<italic>r</italic>&#x02009;&#x0003D;&#x02009;0.2006; <italic>p</italic>&#x02009;&#x0003D;&#x02009;0.0294) and the absolute neutrophil count (ANC). Finally, there was also a significant positive correlation between the levels of MCT (<italic>r</italic>&#x02009;&#x0003D;&#x02009;0.2637; <italic>p</italic>&#x02009;&#x0003D;&#x02009;0.0039) and the absolute basophil count. Next, we assessed the correlation between the post anthelmintic treatment levels of eosinophils, neutrophils, and mast cell granular proteins and the absolute numbers of eosinophils, neutrophils, and basophils. We did not find any significant correlation between granular proteins and the absolute numbers of eosinophils, neutrophils, and basophils at the post-T time point (Figure <xref ref-type="fig" rid="F4">4</xref>B).</p>
<fig id="F4" position="float">
<label>Figure 4</label>
<caption><p>Relationship between eosinophil, neutrophil, and mast cell granular protein levels and absolute numbers of eosinophils, neutrophils, and basophils in <italic>Strongyloides stercoralis</italic> (<italic>Ss</italic>)-infected individuals and following anthelminthic treatment. <bold>(A)</bold> The absolute count of eosinophils was correlated with plasma levels of eosinophil cationic protein (ECP), eosinophil-derived neurotoxin (EDN), eosinophil peroxidase (EPX), and major basic protein (MBP); the absolute count of neutrophils was correlated with plasma levels of neutrophil elastase (NE), myeloperoxidase (MPO), and proteinase-3 (PTN-3), and the absolute count of neutrophils were correlated with plasma levels of mast cell tryptase (MCT), leukotriene C4 (LTC4), and carboxypeptidase A-3 in <italic>Ss</italic>-infected individuals (<italic>n</italic>&#x02009;&#x0003D;&#x02009;60). <bold>(B)</bold> The absolute count of eosinophils correlation with plasma levels of ECP, EDN, EPX, and MBP; the absolute count of neutrophils correlation with plasma levels of NE, MPO, and PTN-3; and the absolute count of neutrophils correlation with plasma levels of MCT, LTC4, and carboxypeptidase A-3 (CPA-3) in <italic>Ss</italic>-infected following anthelmintic treated individuals (<italic>n</italic>&#x02009;&#x0003D;&#x02009;60). <italic>p</italic> and <italic>r</italic> values were calculated using the Spearman rank correlation test using JMP software.</p></caption>
<graphic xlink:href="fimmu-09-00207-g004.tif"/>
</fig>
</sec>
</sec>
<sec id="S4" sec-type="discussion">
<title>Discussion</title>
<p>Eosinophils are one of the foremost components of the immune system, which play a prominent role in parasitic infections. Eosinophilia is a hallmark of helminth infections, and in some host&#x02013;parasite interactions, eosinophils have been witnessed to kill worms and mediate protective immunity (<xref ref-type="bibr" rid="B6">6</xref>, <xref ref-type="bibr" rid="B23">23</xref>, <xref ref-type="bibr" rid="B24">24</xref>). Eosinophils are also presumed to play a role as APCs for the initiation of the primary and secondary Th2 immune responses to <italic>S. stercoralis</italic> (<xref ref-type="bibr" rid="B25">25</xref>), indicating an elemental role for eosinophils at the boundary between innate and adaptive immune responses. Eosinophils have secondary granules, which contain MBP, ECP, EDN, and EPO, and which are directly toxic to the larvae of <italic>S. stercoralis</italic> (<xref ref-type="bibr" rid="B26">26</xref>, <xref ref-type="bibr" rid="B27">27</xref>).</p>
<p>Eosinophils and antibodies play a crucial function in defense mechanisms against <italic>S. stercoralis</italic> larvae in innate (<xref ref-type="bibr" rid="B28">28</xref>) and adaptive immune responses (<xref ref-type="bibr" rid="B29">29</xref>). Previous studies have shown that mice deficient in MBP and (<xref ref-type="bibr" rid="B30">30</xref>) and EPO (<xref ref-type="bibr" rid="B31">31</xref>) are more susceptible to Strongyloides infection. O&#x02019;Connell et al. have shown that MBP involved in eosinophil-mediated larval killing (<xref ref-type="bibr" rid="B12">12</xref>). ECP and EDN possess ribonuclease activity that form pores into the membrane of target cells, facilitating the entry of other toxic molecules into the cells with subsequent degeneration (<xref ref-type="bibr" rid="B26">26</xref>). Plasma levels of eosinophil granule proteins deliver an indirect measure of degranulation in the tissues and are prominently augmented in many helminth-infected patients (<xref ref-type="bibr" rid="B32">32</xref>). Our data also show that eosinophil granular protein levels were increased in INF individuals. Earlier studies on onchocerciasis, lymphatic filarisis, schistosomiasis, and loiasis showed that ECP and EDN/EPX levels were elevated (<xref ref-type="bibr" rid="B32">32</xref>, <xref ref-type="bibr" rid="B33">33</xref>). The serum concentrations of these proteins emerge consequently to reflect the functional activity of the corresponding granulocyte effector system in the host. In our study, we observed that there was a positive correlation between plasma levels of ECP, EPX and MBP, and the AEC, a finding similar to that seen in loiasis (<xref ref-type="bibr" rid="B32">32</xref>, <xref ref-type="bibr" rid="B33">33</xref>). Thus, eosinophil granular proteins appear to reflect eosinophil activation.</p>
<p>Neutrophils are involved in the activation, regulation, and effector functions of innate and adaptive immune cells (<xref ref-type="bibr" rid="B34">34</xref>). NE and PTN-3 are directly involved in intracellular killing of phagocytosed bacteria in phagolysosomes, in conjunction with MPO and reactive oxygen species (<xref ref-type="bibr" rid="B35">35</xref>). During certain helminth infections, as with non-helminth induced inflammation, neutrophils are often the first cells to be recruited; these can mediate a degree of protective immunity against nematode parasites, as has been revealed most conclusively in the <italic>Strongyloides sp</italic>. model (<xref ref-type="bibr" rid="B9">9</xref>, <xref ref-type="bibr" rid="B36">36</xref>, <xref ref-type="bibr" rid="B37">37</xref>). Maximum killing happened by neutrophils when EPO from eosinophils attached to the surface of <italic>S. mansoni</italic> (<xref ref-type="bibr" rid="B38">38</xref>). In other mouse models, purified neutrophils have been shown to independently kill Strongyloides larvae (<xref ref-type="bibr" rid="B39">39</xref>). In addition, neutrophils are known to mediate adult worm killing through an MPO-dependent mechanism (<xref ref-type="bibr" rid="B12">12</xref>, <xref ref-type="bibr" rid="B40">40</xref>). In our study, NE and MPO levels were significantly increased in INF individuals, and the levels were significantly associated with ANCs. This is similar to an earlier study on <italic>Onchocerca volvulus</italic> infection that showed that the plasma level of MPO was correlated with ANC (<xref ref-type="bibr" rid="B32">32</xref>, <xref ref-type="bibr" rid="B41">41</xref>). Changes in the PTN-3 levels may be due to increased production during inflammatory activity and neutrophil or mononuclear cell leakage/degranulation. PTN-3 has antimicrobial properties and is known to efficiently kill bacteria (<xref ref-type="bibr" rid="B41">41</xref>). However, in our study, PTN-3 did not show any significant alterations in Ss infection. Thus, neutrophil granular proteins, similar to their eosinophil counterparts, appear to reflect neutrophil-mediated activation in <italic>Ss</italic> infection.</p>
<p>Mast cell tryptase, CPA-3, and arachidonic acid-derived lipid mediators such as LTC4 are produced during mast cell activation (<xref ref-type="bibr" rid="B42">42</xref>, <xref ref-type="bibr" rid="B43">43</xref>). MCT is a major protein product of human mast cells (<xref ref-type="bibr" rid="B44">44</xref>). During the activation of mast cells, MCT levels have been shown to be elevated in anaphylaxis (<xref ref-type="bibr" rid="B45">45</xref>) and systemic mastocytosis (<xref ref-type="bibr" rid="B46">46</xref>). Infection with <italic>T. spiralis</italic> has shown increased numbers of gastrointestinal tract mast cells and associated levels of LTC4, that was felt to be involved in rapid worm expulsion (<xref ref-type="bibr" rid="B47">47</xref>). In line with these data, INF individuals showed significantly increased levels of MCT, CPA-3, and LTC4 when compared with UN individuals.</p>
<p>Earlier studies have demonstrated that eosinophils and neutrophils are the key players mediating microfilarial killing following anthelmintic treatment (<xref ref-type="bibr" rid="B48">48</xref>). Destruction of parasites occurs through eosinophil degranulation after anthelmintic treatment with DEC or ivermectin (<xref ref-type="bibr" rid="B49">49</xref>, <xref ref-type="bibr" rid="B50">50</xref>). Cooper et al. showed that plasma levels of MCT increased following treatment for onchocerciasis (<xref ref-type="bibr" rid="B51">51</xref>). In this study, we show that the augmented levels of eosinophils, neutrophils, and mast cell granular proteins are significantly diminished at 6&#x02009;months following treatment. This indicates that the release of these granular proteins is intimately related to the presence of active helminth infection and that elimination of the parasite removes the stimulus for increased release of these factors.</p>
<p>Our study adds to the growing body of literature showing the importance of granulocytes and their activation in helminth infections. While the roles of neutrophils in animal models of helminth infections are well studied (<xref ref-type="bibr" rid="B36">36</xref>), very scant data exist on the role of these important innate mediators in human helminth infection. Thus, our study derives strength from the fairly large sample size and the homogeneity of the population studied. Further studies exploring the exact role of these granular proteins should provide valuable insight into the regulation of the protective or pathogenic immune response in helminth infections at large.</p>
</sec>
<sec id="S5">
<title>Ethics Statement</title>
<p>All individuals were examined as part of a natural history study protocol approved by Institutional Review Boards of the National Institute of Allergy and Infectious Diseases (USA) and the National Institute for Research in Tuberculosis (India), and informed written consent was obtained from all participants.</p>
</sec>
<sec id="S6" sec-type="author-contributor">
<title>Author Contributions</title>
<p>Conceived and designed the experiments: AR and SB. Performed the experiments: AR, SM, and YB. Analyzed the data: AR and SB. Contributed reagents/materials/analysis tools: CD and TN. Wrote the paper: AR, TN, and SB.</p>
</sec>
<sec id="S7">
<title>Conflict of Interest Statement</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The reviewer WK and handling Editor declared their shared affiliation.</p>
</sec>
</body>
<back>
<ack>
<p>We thank Dr. M. Satiswaran and Prabbu Balakrishnan for valuable assistance in collecting the clinical data for this study. We thank the staff of the Department of Epidemiology, NIRT, for valuable assistance in recruiting the patients for this study.</p>
</ack>
<fn-group>
<fn fn-type="financial-disclosure">
<p><bold>Funding.</bold> This work was funded by the Division of Intramural Research, NIAID, NIH.</p></fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="B1"><label>1</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Puthiyakunnon</surname> <given-names>S</given-names></name> <name><surname>Boddu</surname> <given-names>S</given-names></name> <name><surname>Li</surname> <given-names>Y</given-names></name> <name><surname>Zhou</surname> <given-names>X</given-names></name> <name><surname>Wang</surname> <given-names>C</given-names></name> <name><surname>Li</surname> <given-names>J</given-names></name> <etal/></person-group> <article-title>Strongyloidiasis &#x02013; an insight into its global prevalence and management</article-title>. <source>PLoS Negl Trop Dis</source> (<year>2014</year>) <volume>8</volume>:<fpage>e3018</fpage>.<pub-id pub-id-type="doi">10.1371/journal.pntd.0003018</pub-id></citation></ref>
<ref id="B2"><label>2</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Oppenheim</surname> <given-names>JJ</given-names></name> <name><surname>Yang</surname> <given-names>D</given-names></name></person-group>. <article-title>Alarmins: chemotactic activators of immune responses</article-title>. <source>Curr Opin Immunol</source> (<year>2005</year>) <volume>17</volume>:<fpage>359</fpage>&#x02013;<lpage>65</lpage>.<pub-id pub-id-type="doi">10.1016/j.coi.2005.06.002</pub-id><pub-id pub-id-type="pmid">15955682</pub-id></citation></ref>
<ref id="B3"><label>3</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Reimert</surname> <given-names>CM</given-names></name> <name><surname>Fitzsimmons</surname> <given-names>CM</given-names></name> <name><surname>Joseph</surname> <given-names>S</given-names></name> <name><surname>Mwatha</surname> <given-names>JK</given-names></name> <name><surname>Jones</surname> <given-names>FM</given-names></name> <name><surname>Kimani</surname> <given-names>G</given-names></name> <etal/></person-group> <article-title>Eosinophil activity in <italic>Schistosoma mansoni</italic> infections in vivo and in vitro in relation to plasma cytokine profile pre- and posttreatment with praziquantel</article-title>. <source>Clin Vaccine Immunol</source> (<year>2006</year>) <volume>13</volume>:<fpage>584</fpage>&#x02013;<lpage>93</lpage>.<pub-id pub-id-type="doi">10.1128/CVI.13.5.584-593.2006</pub-id><pub-id pub-id-type="pmid">16682480</pub-id></citation></ref>
<ref id="B4"><label>4</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gessner</surname> <given-names>A</given-names></name> <name><surname>Mohrs</surname> <given-names>K</given-names></name> <name><surname>Mohrs</surname> <given-names>M</given-names></name></person-group>. <article-title>Mast cells, basophils, and eosinophils acquire constitutive IL-4 and IL-13 transcripts during lineage differentiation that are sufficient for rapid cytokine production</article-title>. <source>J Immunol</source> (<year>2005</year>) <volume>174</volume>:<fpage>1063</fpage>&#x02013;<lpage>72</lpage>.<pub-id pub-id-type="doi">10.4049/jimmunol.174.2.1063</pub-id><pub-id pub-id-type="pmid">15634931</pub-id></citation></ref>
<ref id="B5"><label>5</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Walsh</surname> <given-names>GM</given-names></name></person-group>. <article-title>Eosinophil granule proteins and their role in disease</article-title>. <source>Curr Opin Hematol</source> (<year>2001</year>) <volume>8</volume>:<fpage>28</fpage>&#x02013;<lpage>33</lpage>.<pub-id pub-id-type="doi">10.1097/00062752-200101000-00006</pub-id></citation></ref>
<ref id="B6"><label>6</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Klion</surname> <given-names>AD</given-names></name> <name><surname>Nutman</surname> <given-names>TB</given-names></name></person-group>. <article-title>The role of eosinophils in host defense against helminth parasites</article-title>. <source>J Allergy Clin Immunol</source> (<year>2004</year>) <volume>113</volume>:<fpage>30</fpage>&#x02013;<lpage>7</lpage>.<pub-id pub-id-type="doi">10.1016/j.jaci.2003.10.050</pub-id><pub-id pub-id-type="pmid">14713904</pub-id></citation></ref>
<ref id="B7"><label>7</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Brattig</surname> <given-names>NW</given-names></name> <name><surname>Tischendorf</surname> <given-names>FW</given-names></name> <name><surname>Strote</surname> <given-names>G</given-names></name> <name><surname>Medina-De La Garza</surname> <given-names>CE</given-names></name></person-group>. <article-title>Eosinophil-larval-interaction in onchocerciasis: heterogeneity of in vitro adherence of eosinophils to infective third and fourth stage larvae and microfilariae of <italic>Onchocerca volvulus</italic></article-title>. <source>Parasite Immunol</source> (<year>1991</year>) <volume>13</volume>:<fpage>13</fpage>&#x02013;<lpage>22</lpage>.<pub-id pub-id-type="doi">10.1111/j.1365-3024.1991.tb00259.x</pub-id><pub-id pub-id-type="pmid">2014134</pub-id></citation></ref>
<ref id="B8"><label>8</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Herbert</surname> <given-names>DR</given-names></name> <name><surname>Nolan</surname> <given-names>TJ</given-names></name> <name><surname>Schad</surname> <given-names>GA</given-names></name> <name><surname>Abraham</surname> <given-names>D</given-names></name></person-group>. <article-title>The role of B cells in immunity against larval <italic>Strongyloides stercoralis</italic> in mice</article-title>. <source>Parasite Immunol</source> (<year>2002</year>) <volume>24</volume>:<fpage>95</fpage>&#x02013;<lpage>101</lpage>.<pub-id pub-id-type="doi">10.1046/j.0141-9838.2001.00441.x</pub-id><pub-id pub-id-type="pmid">11874564</pub-id></citation></ref>
<ref id="B9"><label>9</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Watanabe</surname> <given-names>K</given-names></name> <name><surname>Noda</surname> <given-names>K</given-names></name> <name><surname>Hamano</surname> <given-names>S</given-names></name> <name><surname>Koga</surname> <given-names>M</given-names></name> <name><surname>Kishihara</surname> <given-names>K</given-names></name> <name><surname>Nomoto</surname> <given-names>K</given-names></name> <etal/></person-group> <article-title>The crucial role of granulocytes in the early host defense against <italic>Strongyloides ratti</italic> infection in mice</article-title>. <source>Parasitol Res</source> (<year>2000</year>) <volume>86</volume>:<fpage>188</fpage>&#x02013;<lpage>93</lpage>.<pub-id pub-id-type="doi">10.1007/s004360050030</pub-id><pub-id pub-id-type="pmid">10726988</pub-id></citation></ref>
<ref id="B10"><label>10</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jong</surname> <given-names>EC</given-names></name> <name><surname>Mahmoud</surname> <given-names>AA</given-names></name> <name><surname>Klebanoff</surname> <given-names>SJ</given-names></name></person-group>. <article-title>Peroxidase-mediated toxicity to schistosomula of <italic>Schistosoma mansoni</italic></article-title>. <source>J Immunol</source> (<year>1981</year>) <volume>126</volume>:<fpage>468</fpage>&#x02013;<lpage>71</lpage>.<pub-id pub-id-type="pmid">6256441</pub-id></citation></ref>
<ref id="B11"><label>11</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Buys</surname> <given-names>J</given-names></name> <name><surname>Wever</surname> <given-names>R</given-names></name> <name><surname>Ruitenberg</surname> <given-names>EJ</given-names></name></person-group>. <article-title>Myeloperoxidase is more efficient than eosinophil peroxidase in the in vitro killing of newborn larvae of <italic>Trichinella spiralis</italic></article-title>. <source>Immunology</source> (<year>1984</year>) <volume>51</volume>:<fpage>601</fpage>&#x02013;<lpage>7</lpage>.<pub-id pub-id-type="pmid">6321330</pub-id></citation></ref>
<ref id="B12"><label>12</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>O&#x02019;Connell</surname> <given-names>AE</given-names></name> <name><surname>Hess</surname> <given-names>JA</given-names></name> <name><surname>Santiago</surname> <given-names>GA</given-names></name> <name><surname>Nolan</surname> <given-names>TJ</given-names></name> <name><surname>Lok</surname> <given-names>JB</given-names></name> <name><surname>Lee</surname> <given-names>JJ</given-names></name> <etal/></person-group> <article-title>Major basic protein from eosinophils and myeloperoxidase from neutrophils are required for protective immunity to <italic>Strongyloides stercoralis</italic> in mice</article-title>. <source>Infect Immun</source> (<year>2011</year>) <volume>79</volume>:<fpage>2770</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="doi">10.1128/IAI.00931-10</pub-id><pub-id pub-id-type="pmid">21482685</pub-id></citation></ref>
<ref id="B13"><label>13</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Freudenstein-Dan</surname> <given-names>A</given-names></name> <name><surname>Gold</surname> <given-names>D</given-names></name> <name><surname>Fishelson</surname> <given-names>Z</given-names></name></person-group>. <article-title>Killing of schistosomes by elastase and hydrogen peroxide: implications for leukocyte-mediated schistosome killing</article-title>. <source>J Parasitol</source> (<year>2003</year>) <volume>89</volume>:<fpage>1129</fpage>&#x02013;<lpage>35</lpage>.<pub-id pub-id-type="doi">10.1645/GE-96R</pub-id><pub-id pub-id-type="pmid">14740899</pub-id></citation></ref>
<ref id="B14"><label>14</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bulfone-Paus</surname> <given-names>S</given-names></name> <name><surname>Bahri</surname> <given-names>R</given-names></name></person-group>. <article-title>Mast cells as regulators of T cell responses</article-title>. <source>Front Immunol</source> (<year>2015</year>) <volume>6</volume>:<fpage>394</fpage>.<pub-id pub-id-type="doi">10.3389/fimmu.2015.00394</pub-id><pub-id pub-id-type="pmid">26300882</pub-id></citation></ref>
<ref id="B15"><label>15</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Weller</surname> <given-names>CL</given-names></name> <name><surname>Collington</surname> <given-names>SJ</given-names></name> <name><surname>Williams</surname> <given-names>T</given-names></name> <name><surname>Lamb</surname> <given-names>JR</given-names></name></person-group>. <article-title>Mast cells in health and disease</article-title>. <source>Clin Sci (Lond)</source> (<year>2011</year>) <volume>120</volume>:<fpage>473</fpage>&#x02013;<lpage>84</lpage>.<pub-id pub-id-type="doi">10.1042/CS20100459</pub-id></citation></ref>
<ref id="B16"><label>16</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Melendez</surname> <given-names>AJ</given-names></name> <name><surname>Harnett</surname> <given-names>MM</given-names></name> <name><surname>Pushparaj</surname> <given-names>PN</given-names></name> <name><surname>Wong</surname> <given-names>WS</given-names></name> <name><surname>Tay</surname> <given-names>HK</given-names></name> <name><surname>Mcsharry</surname> <given-names>CP</given-names></name> <etal/></person-group> <article-title>Inhibition of Fc epsilon RI-mediated mast cell responses by ES-62, a product of parasitic filarial nematodes</article-title>. <source>Nat Med</source> (<year>2007</year>) <volume>13</volume>:<fpage>1375</fpage>&#x02013;<lpage>81</lpage>.<pub-id pub-id-type="doi">10.1038/nm1654</pub-id><pub-id pub-id-type="pmid">17952092</pub-id></citation></ref>
<ref id="B17"><label>17</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pennock</surname> <given-names>JL</given-names></name> <name><surname>Grencis</surname> <given-names>RK</given-names></name></person-group>. <article-title>The mast cell and gut nematodes: damage and defence</article-title>. <source>Chem Immunol Allergy</source> (<year>2006</year>) <volume>90</volume>:<fpage>128</fpage>&#x02013;<lpage>40</lpage>.<pub-id pub-id-type="doi">10.1159/000088885</pub-id><pub-id pub-id-type="pmid">16210907</pub-id></citation></ref>
<ref id="B18"><label>18</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Abe</surname> <given-names>T</given-names></name> <name><surname>Nawa</surname> <given-names>Y</given-names></name></person-group>. <article-title>Worm expulsion and mucosal mast cell response induced by repetitive IL-3 administration in <italic>Strongyloides ratti</italic>-infected nude mice</article-title>. <source>Immunology</source> (<year>1988</year>) <volume>63</volume>:<fpage>181</fpage>&#x02013;<lpage>5</lpage>.<pub-id pub-id-type="pmid">3258270</pub-id></citation></ref>
<ref id="B19"><label>19</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Marshall</surname> <given-names>JS</given-names></name></person-group>. <article-title>Mast-cell responses to pathogens</article-title>. <source>Nat Rev Immunol</source> (<year>2004</year>) <volume>4</volume>:<fpage>787</fpage>&#x02013;<lpage>99</lpage>.<pub-id pub-id-type="doi">10.1038/nri1460</pub-id><pub-id pub-id-type="pmid">15459670</pub-id></citation></ref>
<ref id="B20"><label>20</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bisoffi</surname> <given-names>Z</given-names></name> <name><surname>Buonfrate</surname> <given-names>D</given-names></name> <name><surname>Sequi</surname> <given-names>M</given-names></name> <name><surname>Mejia</surname> <given-names>R</given-names></name> <name><surname>Cimino</surname> <given-names>RO</given-names></name> <name><surname>Krolewiecki</surname> <given-names>AJ</given-names></name> <etal/></person-group> <article-title>Diagnostic accuracy of five serologic tests for <italic>Strongyloides stercoralis</italic> infection</article-title>. <source>PLoS Negl Trop Dis</source> (<year>2014</year>) <volume>8</volume>:<fpage>e2640</fpage>.<pub-id pub-id-type="doi">10.1371/journal.pntd.0002640</pub-id><pub-id pub-id-type="pmid">24427320</pub-id></citation></ref>
<ref id="B21"><label>21</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Buonfrate</surname> <given-names>D</given-names></name> <name><surname>Sequi</surname> <given-names>M</given-names></name> <name><surname>Mejia</surname> <given-names>R</given-names></name> <name><surname>Cimino</surname> <given-names>RO</given-names></name> <name><surname>Krolewiecki</surname> <given-names>AJ</given-names></name> <name><surname>Albonico</surname> <given-names>M</given-names></name> <etal/></person-group> <article-title>Accuracy of five serologic tests for the follow up of <italic>Strongyloides stercoralis</italic> infection</article-title>. <source>PLoS Negl Trop Dis</source> (<year>2015</year>) <volume>9</volume>:<fpage>e0003491</fpage>.<pub-id pub-id-type="doi">10.1371/journal.pntd.0003491</pub-id><pub-id pub-id-type="pmid">25668740</pub-id></citation></ref>
<ref id="B22"><label>22</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sato</surname> <given-names>Y</given-names></name> <name><surname>Kobayashi</surname> <given-names>J</given-names></name> <name><surname>Toma</surname> <given-names>H</given-names></name> <name><surname>Shiroma</surname> <given-names>Y</given-names></name></person-group>. <article-title>Efficacy of stool examination for detection of <italic>Strongyloides</italic> infection</article-title>. <source>Am J Trop Med Hyg</source> (<year>1995</year>) <volume>53</volume>:<fpage>248</fpage>&#x02013;<lpage>50</lpage>.<pub-id pub-id-type="doi">10.4269/ajtmh.1995.53.248</pub-id><pub-id pub-id-type="pmid">7573706</pub-id></citation></ref>
<ref id="B23"><label>23</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname> <given-names>L</given-names></name> <name><surname>Appleton</surname> <given-names>JA</given-names></name></person-group>. <article-title>Eosinophils in helminth infection: defenders and dupes</article-title>. <source>Trends Parasitol</source> (<year>2016</year>) <volume>32</volume>:<fpage>798</fpage>&#x02013;<lpage>807</lpage>.<pub-id pub-id-type="doi">10.1016/j.pt.2016.05.004</pub-id><pub-id pub-id-type="pmid">27262918</pub-id></citation></ref>
<ref id="B24"><label>24</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname> <given-names>L</given-names></name> <name><surname>Gebreselassie</surname> <given-names>NG</given-names></name> <name><surname>Gagliardo</surname> <given-names>LF</given-names></name> <name><surname>Ruyechan</surname> <given-names>MC</given-names></name> <name><surname>Luber</surname> <given-names>KL</given-names></name> <name><surname>Lee</surname> <given-names>NA</given-names></name> <etal/></person-group> <article-title>Eosinophils mediate protective immunity against secondary nematode infection</article-title>. <source>J Immunol</source> (<year>2015</year>) <volume>194</volume>:<fpage>283</fpage>&#x02013;<lpage>90</lpage>.<pub-id pub-id-type="doi">10.4049/jimmunol.1402219</pub-id><pub-id pub-id-type="pmid">25429065</pub-id></citation></ref>
<ref id="B25"><label>25</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Padigel</surname> <given-names>UM</given-names></name> <name><surname>Lee</surname> <given-names>JJ</given-names></name> <name><surname>Nolan</surname> <given-names>TJ</given-names></name> <name><surname>Schad</surname> <given-names>GA</given-names></name> <name><surname>Abraham</surname> <given-names>D</given-names></name></person-group>. <article-title>Eosinophils can function as antigen-presenting cells to induce primary and secondary immune responses to <italic>Strongyloides stercoralis</italic></article-title>. <source>Infect Immun</source> (<year>2006</year>) <volume>74</volume>:<fpage>3232</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="doi">10.1128/IAI.02067-05</pub-id><pub-id pub-id-type="pmid">16714550</pub-id></citation></ref>
<ref id="B26"><label>26</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Weller</surname> <given-names>PF</given-names></name></person-group>. <article-title>The immunobiology of eosinophils</article-title>. <source>N Engl J Med</source> (<year>1991</year>) <volume>324</volume>:<fpage>1110</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="doi">10.1056/NEJM199104183241607</pub-id></citation></ref>
<ref id="B27"><label>27</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zuo</surname> <given-names>L</given-names></name> <name><surname>Rothenberg</surname> <given-names>ME</given-names></name></person-group>. <article-title>Gastrointestinal eosinophilia</article-title>. <source>Immunol Allergy Clin North Am</source> (<year>2007</year>) <volume>27</volume>:<fpage>443</fpage>&#x02013;<lpage>55</lpage>.<pub-id pub-id-type="doi">10.1016/j.iac.2007.06.002</pub-id><pub-id pub-id-type="pmid">17868858</pub-id></citation></ref>
<ref id="B28"><label>28</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Satoh</surname> <given-names>M</given-names></name> <name><surname>Toma</surname> <given-names>H</given-names></name> <name><surname>Sato</surname> <given-names>Y</given-names></name> <name><surname>Kikuchi</surname> <given-names>M</given-names></name> <name><surname>Takara</surname> <given-names>M</given-names></name> <name><surname>Shiroma</surname> <given-names>Y</given-names></name> <etal/></person-group> <article-title>Production of a high level of specific IgG4 antibody associated with resistance to albendazole treatment in HLA-DRB1&#x0002A;0901-positive patients with strongyloidiasis</article-title>. <source>Am J Trop Med Hyg</source> (<year>1999</year>) <volume>61</volume>:<fpage>668</fpage>&#x02013;<lpage>71</lpage>.<pub-id pub-id-type="doi">10.4269/ajtmh.1999.61.668</pub-id><pub-id pub-id-type="pmid">10548308</pub-id></citation></ref>
<ref id="B29"><label>29</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mir</surname> <given-names>A</given-names></name> <name><surname>Benahmed</surname> <given-names>D</given-names></name> <name><surname>Igual</surname> <given-names>R</given-names></name> <name><surname>Borras</surname> <given-names>R</given-names></name> <name><surname>O&#x02019;Connor</surname> <given-names>JE</given-names></name> <name><surname>Moreno</surname> <given-names>MJ</given-names></name> <etal/></person-group> <article-title>Eosinophil-selective mediators in human strongyloidiasis</article-title>. <source>Parasite Immunol</source> (<year>2006</year>) <volume>28</volume>:<fpage>397</fpage>&#x02013;<lpage>400</lpage>.<pub-id pub-id-type="doi">10.1111/j.1365-3024.2006.00826.x</pub-id><pub-id pub-id-type="pmid">16879311</pub-id></citation></ref>
<ref id="B30"><label>30</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Denzler</surname> <given-names>KL</given-names></name> <name><surname>Farmer</surname> <given-names>SC</given-names></name> <name><surname>Crosby</surname> <given-names>JR</given-names></name> <name><surname>Borchers</surname> <given-names>M</given-names></name> <name><surname>Cieslewicz</surname> <given-names>G</given-names></name> <name><surname>Larson</surname> <given-names>KA</given-names></name> <etal/></person-group> <article-title>Eosinophil major basic protein-1 does not contribute to allergen-induced airway pathologies in mouse models of asthma</article-title>. <source>J Immunol</source> (<year>2000</year>) <volume>165</volume>:<fpage>5509</fpage>&#x02013;<lpage>17</lpage>.<pub-id pub-id-type="doi">10.4049/jimmunol.165.10.5509</pub-id></citation></ref>
<ref id="B31"><label>31</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Denzler</surname> <given-names>KL</given-names></name> <name><surname>Borchers</surname> <given-names>MT</given-names></name> <name><surname>Crosby</surname> <given-names>JR</given-names></name> <name><surname>Cieslewicz</surname> <given-names>G</given-names></name> <name><surname>Hines</surname> <given-names>EM</given-names></name> <name><surname>Justice</surname> <given-names>JP</given-names></name> <etal/></person-group> <article-title>Extensive eosinophil degranulation and peroxidase-mediated oxidation of airway proteins do not occur in a mouse ovalbumin-challenge model of pulmonary inflammation</article-title>. <source>J Immunol</source> (<year>2001</year>) <volume>167</volume>:<fpage>1672</fpage>&#x02013;<lpage>82</lpage>.<pub-id pub-id-type="doi">10.4049/jimmunol.167.3.1672</pub-id><pub-id pub-id-type="pmid">11466391</pub-id></citation></ref>
<ref id="B32"><label>32</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tischendorf</surname> <given-names>FW</given-names></name> <name><surname>Brattig</surname> <given-names>NW</given-names></name> <name><surname>Burchard</surname> <given-names>GD</given-names></name> <name><surname>Kubica</surname> <given-names>T</given-names></name> <name><surname>Kreuzpaintner</surname> <given-names>G</given-names></name> <name><surname>Lintzel</surname> <given-names>M</given-names></name></person-group>. <article-title>Eosinophils, eosinophil cationic protein and eosinophil-derived neurotoxin in serum and urine of patients with onchocerciasis coinfected with intestinal nematodes and in urinary schistosomiasis</article-title>. <source>Acta Trop</source> (<year>1999</year>) <volume>72</volume>:<fpage>157</fpage>&#x02013;<lpage>73</lpage>.<pub-id pub-id-type="doi">10.1016/S0001-706X(98)00088-6</pub-id><pub-id pub-id-type="pmid">10206116</pub-id></citation></ref>
<ref id="B33"><label>33</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Herrick</surname> <given-names>JA</given-names></name> <name><surname>Metenou</surname> <given-names>S</given-names></name> <name><surname>Makiya</surname> <given-names>MA</given-names></name> <name><surname>Taylar-Williams</surname> <given-names>CA</given-names></name> <name><surname>Law</surname> <given-names>MA</given-names></name> <name><surname>Klion</surname> <given-names>AD</given-names></name> <etal/></person-group> <article-title>Eosinophil-associated processes underlie differences in clinical presentation of loiasis between temporary residents and those indigenous to Loa-endemic areas</article-title>. <source>Clin Infect Dis</source> (<year>2015</year>) <volume>60</volume>:<fpage>55</fpage>&#x02013;<lpage>63</lpage>.<pub-id pub-id-type="doi">10.1093/cid/ciu723</pub-id><pub-id pub-id-type="pmid">25234520</pub-id></citation></ref>
<ref id="B34"><label>34</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mantovani</surname> <given-names>A</given-names></name> <name><surname>Cassatella</surname> <given-names>MA</given-names></name> <name><surname>Costantini</surname> <given-names>C</given-names></name> <name><surname>Jaillon</surname> <given-names>S</given-names></name></person-group>. <article-title>Neutrophils in the activation and regulation of innate and adaptive immunity</article-title>. <source>Nat Rev Immunol</source> (<year>2011</year>) <volume>11</volume>:<fpage>519</fpage>&#x02013;<lpage>31</lpage>.<pub-id pub-id-type="doi">10.1038/nri3024</pub-id><pub-id pub-id-type="pmid">21785456</pub-id></citation></ref>
<ref id="B35"><label>35</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kobayashi</surname> <given-names>SD</given-names></name> <name><surname>Voyich</surname> <given-names>JM</given-names></name> <name><surname>Burlak</surname> <given-names>C</given-names></name> <name><surname>DeLeo</surname> <given-names>FR</given-names></name></person-group>. <article-title>Neutrophils in the innate immune response</article-title>. <source>Arch Immunol Ther Exp (Warsz)</source> (<year>2005</year>) <volume>53</volume>(<issue>6</issue>):<fpage>505</fpage>&#x02013;<lpage>17</lpage>.<pub-id pub-id-type="pmid">16407783</pub-id></citation></ref>
<ref id="B36"><label>36</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bonne-Annee</surname> <given-names>S</given-names></name> <name><surname>Kerepesi</surname> <given-names>LA</given-names></name> <name><surname>Hess</surname> <given-names>JA</given-names></name> <name><surname>O&#x02019;Connell</surname> <given-names>AE</given-names></name> <name><surname>Lok</surname> <given-names>JB</given-names></name> <name><surname>Nolan</surname> <given-names>TJ</given-names></name> <etal/></person-group> <article-title>Human and mouse macrophages collaborate with neutrophils to kill larval <italic>Strongyloides stercoralis</italic></article-title>. <source>Infect Immun</source> (<year>2013</year>) <volume>81</volume>:<fpage>3346</fpage>&#x02013;<lpage>55</lpage>.<pub-id pub-id-type="doi">10.1128/IAI.00625-13</pub-id><pub-id pub-id-type="pmid">23798541</pub-id></citation></ref>
<ref id="B37"><label>37</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bonne-Annee</surname> <given-names>S</given-names></name> <name><surname>Hess</surname> <given-names>JA</given-names></name> <name><surname>Abraham</surname> <given-names>D</given-names></name></person-group>. <article-title>Innate and adaptive immunity to the nematode <italic>Strongyloides stercoralis</italic> in a mouse model</article-title>. <source>Immunol Res</source> (<year>2011</year>) <volume>51</volume>:<fpage>205</fpage>&#x02013;<lpage>14</lpage>.<pub-id pub-id-type="doi">10.1007/s12026-011-8258-2</pub-id><pub-id pub-id-type="pmid">22101674</pub-id></citation></ref>
<ref id="B38"><label>38</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jong</surname> <given-names>EC</given-names></name> <name><surname>Chi</surname> <given-names>EY</given-names></name> <name><surname>Klebanoff</surname> <given-names>SJ</given-names></name></person-group>. <article-title>Human neutrophil-mediated killing of schistosomula of <italic>Schistosoma mansoni</italic>: augmentation by schistosomal binding of eosinophil peroxidase</article-title>. <source>Am J Trop Med Hyg</source> (<year>1984</year>) <volume>33</volume>:<fpage>104</fpage>&#x02013;<lpage>15</lpage>.<pub-id pub-id-type="doi">10.4269/ajtmh.1984.33.104</pub-id><pub-id pub-id-type="pmid">6696169</pub-id></citation></ref>
<ref id="B39"><label>39</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Galioto</surname> <given-names>AM</given-names></name> <name><surname>Hess</surname> <given-names>JA</given-names></name> <name><surname>Nolan</surname> <given-names>TJ</given-names></name> <name><surname>Schad</surname> <given-names>GA</given-names></name> <name><surname>Lee</surname> <given-names>JJ</given-names></name> <name><surname>Abraham</surname> <given-names>D</given-names></name></person-group>. <article-title>Role of eosinophils and neutrophils in innate and adaptive protective immunity to larval <italic>Strongyloides stercoralis</italic> in mice</article-title>. <source>Infect Immun</source> (<year>2006</year>) <volume>74</volume>:<fpage>5730</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="doi">10.1128/IAI.01958-05</pub-id><pub-id pub-id-type="pmid">16988250</pub-id></citation></ref>
<ref id="B40"><label>40</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Doyle</surname> <given-names>AD</given-names></name> <name><surname>Jacobsen</surname> <given-names>EA</given-names></name> <name><surname>Ochkur</surname> <given-names>SI</given-names></name> <name><surname>Mcgarry</surname> <given-names>MP</given-names></name> <name><surname>Shim</surname> <given-names>KG</given-names></name> <name><surname>Nguyen</surname> <given-names>DT</given-names></name> <etal/></person-group> <article-title>Expression of the secondary granule proteins major basic protein 1 (MBP-1) and eosinophil peroxidase (EPX) is required for eosinophilopoiesis in mice</article-title>. <source>Blood</source> (<year>2013</year>) <volume>122</volume>:<fpage>781</fpage>&#x02013;<lpage>90</lpage>.<pub-id pub-id-type="doi">10.1182/blood-2013-01-473405</pub-id><pub-id pub-id-type="pmid">23736699</pub-id></citation></ref>
<ref id="B41"><label>41</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>S&#x000F8;rensen</surname> <given-names>OE</given-names></name> <name><surname>Follin</surname> <given-names>P</given-names></name> <name><surname>Johnsen</surname> <given-names>AH</given-names></name> <name><surname>Calafat</surname> <given-names>J</given-names></name> <name><surname>Tjabringa</surname> <given-names>GS</given-names></name> <name><surname>Hiemstra</surname> <given-names>PS</given-names></name> <etal/></person-group> <article-title>Human cathelicidin, hCAP-18, is processed to the antimicrobial peptide LL-37 by extracellular cleavage with proteinase 3</article-title>. <source>Blood</source> (<year>2001</year>) <volume>97</volume>:<fpage>3951</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="doi">10.1182/blood.V97.12.3951</pub-id>.</citation></ref>
<ref id="B42"><label>42</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Goldstein</surname> <given-names>SM</given-names></name> <name><surname>Kaempfer</surname> <given-names>CE</given-names></name> <name><surname>Proud</surname> <given-names>D</given-names></name> <name><surname>Schwartz</surname> <given-names>LB</given-names></name> <name><surname>Irani</surname> <given-names>AM</given-names></name> <name><surname>Wintroub</surname> <given-names>BU</given-names></name></person-group>. <article-title>Detection and partial characterization of a human mast cell carboxypeptidase</article-title>. <source>J Immunol</source> (<year>1987</year>) <volume>139</volume>:<fpage>2724</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="pmid">2443571</pub-id></citation></ref>
<ref id="B43"><label>43</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Schechter</surname> <given-names>NM</given-names></name> <name><surname>Irani</surname> <given-names>AM</given-names></name> <name><surname>Sprows</surname> <given-names>JL</given-names></name> <name><surname>Abernethy</surname> <given-names>J</given-names></name> <name><surname>Wintroub</surname> <given-names>B</given-names></name> <name><surname>Schwartz</surname> <given-names>LB</given-names></name></person-group>. <article-title>Identification of a cathepsin G-like proteinase in the MCTC type of human mast cell</article-title>. <source>J Immunol</source> (<year>1990</year>) <volume>145</volume>:<fpage>2652</fpage>&#x02013;<lpage>61</lpage>.<pub-id pub-id-type="pmid">2212656</pub-id></citation></ref>
<ref id="B44"><label>44</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Schwartz</surname> <given-names>LB</given-names></name></person-group>. <article-title>Diagnostic value of tryptase in anaphylaxis and mastocytosis</article-title>. <source>Immunol Allergy Clin North Am</source> (<year>2006</year>) <volume>26</volume>:<fpage>451</fpage>&#x02013;<lpage>63</lpage>.<pub-id pub-id-type="doi">10.1016/j.iac.2006.05.010</pub-id><pub-id pub-id-type="pmid">16931288</pub-id></citation></ref>
<ref id="B45"><label>45</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Vliagoftis</surname> <given-names>H</given-names></name> <name><surname>Lacy</surname> <given-names>P</given-names></name> <name><surname>Luy</surname> <given-names>B</given-names></name> <name><surname>Adamko</surname> <given-names>D</given-names></name> <name><surname>Hollenberg</surname> <given-names>M</given-names></name> <name><surname>Befus</surname> <given-names>D</given-names></name> <etal/></person-group> <article-title>Mast cell tryptase activates peripheral blood eosinophils to release granule-associated enzymes</article-title>. <source>Int Arch Allergy Immunol</source> (<year>2004</year>) <volume>135</volume>:<fpage>196</fpage>&#x02013;<lpage>204</lpage>.<pub-id pub-id-type="doi">10.1159/000081304</pub-id><pub-id pub-id-type="pmid">15467372</pub-id></citation></ref>
<ref id="B46"><label>46</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Stone</surname> <given-names>KD</given-names></name> <name><surname>Prussin</surname> <given-names>C</given-names></name> <name><surname>Metcalfe</surname> <given-names>DD</given-names></name></person-group>. <article-title>IgE, mast cells, basophils, and eosinophils</article-title>. <source>J Allergy Clin Immunol</source> (<year>2010</year>) <volume>125</volume>:<fpage>S73</fpage>&#x02013;<lpage>80</lpage>.<pub-id pub-id-type="doi">10.1016/j.jaci.2009.11.017</pub-id><pub-id pub-id-type="pmid">20176269</pub-id></citation></ref>
<ref id="B47"><label>47</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Knight</surname> <given-names>PA</given-names></name> <name><surname>Brown</surname> <given-names>JK</given-names></name> <name><surname>Pemberton</surname> <given-names>AD</given-names></name></person-group>. <article-title>Innate immune response mechanisms in the intestinal epithelium: potential roles for mast cells and goblet cells in the expulsion of adult <italic>Trichinella spiralis</italic></article-title>. <source>Parasitology</source> (<year>2008</year>) <volume>135</volume>:<fpage>655</fpage>&#x02013;<lpage>70</lpage>.<pub-id pub-id-type="doi">10.1017/S0031182008004319</pub-id><pub-id pub-id-type="pmid">18413001</pub-id></citation></ref>
<ref id="B48"><label>48</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tischendorf</surname> <given-names>FW</given-names></name> <name><surname>Brattig</surname> <given-names>NW</given-names></name> <name><surname>Hoyer</surname> <given-names>A</given-names></name> <name><surname>Medina-De La Garza</surname> <given-names>CE</given-names></name> <name><surname>Geisinger</surname> <given-names>F</given-names></name></person-group>. <article-title>Modulatory effects of antifilarial drugs ivermectin, CGP 6140 and CGP 20376 on the oxidative burst of eosinophilic granulocytes</article-title>. <source>Acta Trop</source> (<year>1993</year>) <volume>53</volume>:<fpage>27</fpage>&#x02013;<lpage>37</lpage>.<pub-id pub-id-type="doi">10.1016/0001-706X(93)90003-T</pub-id></citation></ref>
<ref id="B49"><label>49</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Racz</surname> <given-names>P</given-names></name> <name><surname>Tenner-Racz</surname> <given-names>K</given-names></name> <name><surname>Luther</surname> <given-names>B</given-names></name> <name><surname>Buttner</surname> <given-names>DW</given-names></name> <name><surname>Albiez</surname> <given-names>EJ</given-names></name></person-group>. <article-title>Immunopathologic aspects in human onchocercal lymphadenitis</article-title>. <source>Bull Soc Pathol Exot Filiales</source> (<year>1983</year>) <volume>76</volume>:<fpage>676</fpage>&#x02013;<lpage>80</lpage>.<pub-id pub-id-type="pmid">6673859</pub-id></citation></ref>
<ref id="B50"><label>50</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wildenburg</surname> <given-names>G</given-names></name> <name><surname>Darge</surname> <given-names>K</given-names></name> <name><surname>Knab</surname> <given-names>J</given-names></name> <name><surname>Tischendorf</surname> <given-names>FW</given-names></name> <name><surname>Bonow</surname> <given-names>I</given-names></name> <name><surname>Buttner</surname> <given-names>DW</given-names></name></person-group>. <article-title>Lymph nodes of onchocerciasis patients after treatment with ivermectin: reaction of eosinophil granulocytes and their cationic granule proteins</article-title>. <source>Trop Med Parasitol</source> (<year>1994</year>) <volume>45</volume>:<fpage>87</fpage>&#x02013;<lpage>96</lpage>.<pub-id pub-id-type="pmid">7939167</pub-id></citation></ref>
<ref id="B51"><label>51</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cooper</surname> <given-names>PJ</given-names></name> <name><surname>Schwartz</surname> <given-names>LB</given-names></name> <name><surname>Irani</surname> <given-names>AM</given-names></name> <name><surname>Awadzi</surname> <given-names>K</given-names></name> <name><surname>Guderian</surname> <given-names>RH</given-names></name> <name><surname>Nutman</surname> <given-names>TB</given-names></name></person-group>. <article-title>Association of transient dermal mastocytosis and elevated plasma tryptase levels with development of adverse reactions after treatment of onchocerciasis with ivermectin</article-title>. <source>J Infect Dis</source> (<year>2002</year>) <volume>186</volume>:<fpage>1307</fpage>&#x02013;<lpage>13</lpage>.<pub-id pub-id-type="doi">10.1086/344318</pub-id><pub-id pub-id-type="pmid">12402200</pub-id></citation></ref>
</ref-list>
</back>
</article>